Related Experiment Video
Updated: Dec 19, 2025

A Macrophage-Tumor Spheroid Co-Invasion Assay
Published on: January 24, 2025
Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site
Elaheh Nasrollahzadeh1,2, Sepideh Razi2,3, Mahsa Keshavarz-Fathi2,4
1School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Abstract:
The tumor microenvironment (TME) not only facilitates cancer progression from the early formation to distant metastasis, but also it differs itself from time to time alongside the tumor evolution. Tumor-associated macrophages (TAMs), whether as pre-existing tissue-resident macrophages or recruited monocytes, are an inseparable part of this microenvironment. As their parents are broadly classified into a dichotomic, simplistic M1 and M2 subtypes, TAMs also exert paradoxical and diverse phenotypes as they are settled in different regions of TME and receive different microenvironmental signals. Briefly, M1 macrophages induce an inflammatory precancerous niche and flame the early oncogenic mutations, whereas their M2 counterparts are reprogrammed to release various growth factors and providing an immunosuppressive state in TME as long as abetting hypoxic cancer cells to set up a new vasculature. Further, they mediate stromal micro-invasion and co-migrate with invasive cancer cells to invade the vascular wall and neural sheath, while another subtype of TAMs prepares suitable niches much earlier than metastatic cells arrive at the target tissues. Accordingly, at the neoplastic transformation, during the benign-to-malignant transition and through the metastatic cascade, macrophages are involved in shaping the primary, micro-invasive and pre-metastatic TMEs. Whether their behavioral plasticity is derived from distinct genotypes or is fueled by microenvironmental cues, it could define these cells as remarkably interesting therapeutic targets.
Insights
Tumor-associated macrophages (TAMs) play a crucial role in cancer progression and metastasis by adopting diverse phenotypes within the tumor microenvironment (TME). Understanding TAM plasticity is key for developing novel cancer therapies.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- The tumor microenvironment (TME) is dynamic and influences cancer progression from initiation to metastasis.
- Tumor-associated macrophages (TAMs) are key cellular components of the TME, exhibiting diverse and context-dependent phenotypes.
- Traditional M1/M2 classification oversimplifies TAM functions, which are critical in shaping the TME.
Purpose of the Study:
- To elucidate the multifaceted roles of TAMs in cancer progression and metastasis.
- To highlight the phenotypic plasticity of TAMs in response to microenvironmental cues.
- To underscore the therapeutic potential of targeting TAMs.
Main Methods:
- Review of existing literature on TAM biology and function in cancer.
- Analysis of TAM involvement across different stages of tumor evolution, including primary tumor formation, invasion, and pre-metastatic niche formation.
- Discussion of TAM polarization and functional divergence within the TME.
Main Results:
- TAMs contribute to early oncogenic mutations (M1-like) and promote tumor growth, angiogenesis, and immunosuppression (M2-like).
- TAMs facilitate cancer cell invasion, intravasation, and the establishment of pre-metastatic niches.
- TAMs are involved in shaping the primary, micro-invasive, and pre-metastatic TMEs.
Conclusions:
- TAMs exhibit remarkable phenotypic plasticity, influenced by the TME, enabling them to support various stages of cancer progression.
- The diverse functions of TAMs make them significant therapeutic targets for cancer treatment.
- Targeting TAMs could offer novel strategies to inhibit tumor evolution and metastasis.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Cell Migration through Invadopodia

